Disease Biomarkers

Date: Thursday, 10 May 2012 - Friday, 11 May 2012
Location: London, England

Keynote Speakers

Sam Hanash
Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center

Overview

Welcome to the Disease Biomarkers track of the Molecular Diagnostics Europe conference and exhibition. This year's event will be held in London.

Other conference tracks at this event include Diagnostic Applications of Exosomes, Point-of-Care Diagnostics and Circulating Tumour Cells. Registered delegates will have access to all four meetings ensuring a very cost-effective trip.

In addition the event will also host two cutting edge business tutorials which can be viewed here.

Agenda Topics

Biomarker Classes: Genomics-based, Proteomics-based, Metabolomics-based
Discovery & Validation Technologies
Gene Signatures for Breast and Colon Cancers: Drivers of Innovation in this Field
Predictive vs. Prognostic Biomarkers

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

, ,
Jason Bielas, Assistant Member, Fred Hutchinson Cancer Research Center
Gary Coulton, Director, St Georges University of London
Darius Dziuda, Associate Professor, Central Connecticut State University
William Gallaghr, Chief Scientific Officer/Professor, OncoMark Limited/University College Dublin
Spiros Garbis, Associate Professor/Head, University of Southampton
Niklas Mattsson, Medical Doctor & Researcher, Sahlgrens University Hospital
Richard Morgan, Senior Lecturer, University of Surrey
Kay Ohlendieck, Professor, National University of Ireland
Salvatore Pernagallo, Product Development Manager, DestiNA Genomics Ltd
Hazel Pinheiro, Senior Scientist, Exiqon
Enal Razvi, Managing Director, Select Biosciences Inc
Cristiana Tanase, Proteomics Group Leader, "Victor Babes" National Institute of Pathology
Paul Tempst, Professor, Memorial Sloan-Kettering Cancer Center
John Timms, Group Leader, University College London
Christoph Turck, Head, Max Planck Institute of Psychiatry
Saskia Vosslamber, Researcher, VU University Medical Center